CervoMed Inc.: Form 10-Q for the period ended Sep 30, 2025
Filed with the SEC on Nov 7, 2025 and accepted by EDGAR at Nov 7, 2025, 16:47 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-07-01 to 2025-09-30 | $322.6k | us-gaap:Revenues |
| Revenue | 9 months2025-01-01 to 2025-09-30 | $4.0m | us-gaap:Revenues |
| Research and development | 3 months2025-07-01 to 2025-09-30 | $6.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2025-01-01 to 2025-09-30 | $16.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2025-07-01 to 2025-09-30 | −$8.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2025-01-01 to 2025-09-30 | −$20.0m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2025-07-01 to 2025-09-30 | −$7.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-01-01 to 2025-09-30 | −$18.9m | us-gaap:NetIncomeLoss |
| Basic EPS | 3 months2025-07-01 to 2025-09-30 | −$0.84 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-01-01 to 2025-09-30 | −$2.10 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 9 months2025-01-01 to 2025-09-30 | −$16.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2025-09-30 | $9.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-09-30 | $30.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-09-30 | $30.6m | us-gaap:Assets |
| Total liabilities | At period end2025-09-30 | $4.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-09-30 | $26.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-25-033879. Last ingested by Listed: Oct 29, 2026, 16:21 ET. Listed shows no prices and gives no investment advice.